Developer docs
API playgroundTry for free, no card

Search company profiles

Additive Orthopaedics

Full company profile

uuid0004toq

Namestring
Additive Orthopaedics
Legal namestring
Additive Orthopaedic Technologies Inc.
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Additive Orthopaedics (legal entity Additive Orthopaedic Technologies Inc.) is a privately held orthopedic technology company founded in 2006 and headquartered in Brattleboro, Vermont. The company designs and manufactures patient-specific 3D-printed titanium orthopedic implants using Laser Powder Bed Fusion (LPBF) of medical-grade Ti-6Al-4V alloy. Its core product portfolio addresses complex anatomical defects that off-the-shelf implants cannot solve, including Total Talus Replacement for foot and ankle reconstruction, an Acetabular Revision System for severe hip defects, and Segmental Bone Reconstruction spacers for trauma, oncology, and chronic-infection cases. Each implant is engineered from patient CT/MRI data using AI-assisted anatomical segmentation to produce a digital twin, with proprietary lattice geometries (600-800 micron interconnected porosity) designed to match cancellous bone modulus and promote bone in-growth.

The company supplements its physical implant business with three content and service platforms: a Clinical Evidence Hub aggregating multi-centered studies on bone in-growth and longitudinal implant performance, a Regulatory Insight Platform providing guidance on FDA 510(k), De Novo, and PMA pathways, and a Surgeons' Portal for licensed orthopedic practitioners. The company cites 15+ advanced regulatory pathways evaluated, 20+ regulatory pathways evaluated, a 98% evidence-based clinical adoption rate, and 5k+ multi-centered clinical studies coordinated as part of its evidence platform. Additional revenue-adjacent services include clinical research and education offerings and regulatory strategy consulting for medical device companies.

The go-to-market is a direct enterprise field-sales model targeting orthopedic surgeons, healthcare institutions, and medical device companies, with regional North American distribution. Revenue is generated on a quote-based, one-time-per-implant basis for the core products, supplemented by professional services revenue from regulatory and clinical research engagements. Pricing is not publicly disclosed. Total known external funding is $1,000,000 from Asimov Ventures in January 2018, and the company operates with 11-50 employees. The customer base consists of individual surgeons, research institutes, surgical centers, and a small number of medtech firms rather than large hospital system contracts.

Short descriptiontext

Additive Orthopaedics is a privately held medical device company that designs and manufactures patient-specific 3D-printed titanium orthopedic implants using Laser Powder Bed Fusion. It serves orthopedic surgeons, hospitals, and medical device companies with custom implants for complex foot, hip, and segmental bone reconstructions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLittle Silver, United States
HQ citystring
Little Silver
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
3D-printed orthopedic implants, patient-specific titanium implants, orthopedic reconstruction devices, additive manufacturing medical, custom orthopedic solutions
Industry1 code
PRIMARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Orthopedic Implants
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Patient-Specific 3D-Printed Implants
TypeOne Time License
Description

Custom-engineered titanium implants designed for individual patient anatomy, primarily targeting complex orthopedic reconstructions including talus replacements, acetabular revisions, and segmental bone reconstruction.

additiveorthopaedics.com
2Clinical Research & Education Services
TypeProfessional Services
Description

Educational content, research hub services, and clinical evidence resources supporting informed surgical adoption of next-generation orthopedic technologies.

additiveorthopaedics.com
3Regulatory Strategy Services
TypeProfessional Services
Description

Expert resources and guidance on FDA regulatory pathways including 510(k) submissions, De Novo classifications, and Premarket Approvals (PMA) for medical device companies.

additiveorthopaedics.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Additive Orthopaedics designs, engineers, and manufactures patient-specific 3D-printed orthopedic implants using Laser Powder Bed Fusion (LPBF) on medical-grade Ti-6Al-4V titanium alloy, featuring proprietary lattice geometries (600-800 micron porosity) for bone integration. Core offerings include Total Talus Replacement, Acetabular Revision System, and Segmental Bone Reconstruction solutions, complemented by a Clinical Evidence Hub, Regulatory Insight Platform, and a Surgeons' Portal serving healthcare professionals and medical device developers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 98% evidence-based clinical adoption rate
+3 more records
Product overview1 text field

Additive Orthopaedics operates as an innovation and education platform offering patient-specific 3D-printed titanium orthopedic implants alongside clinical and regulatory service platforms. The core product portfolio centers on 3D-Printed Implants utilizing Laser Powder Bed Fusion (LPBF) technology, which includes specialized applications: Total Talus Replacement for foot and ankle reconstruction, Acetabular Revision System for hip reconstruction, and Segmental Bone Reconstruction for trauma/oncology cases. These are complemented by the Clinical Evidence Hub for multi-centered research and the Regulatory Insight Platform for FDA pathway guidance. The company also maintains a Surgeons' Portal for healthcare professional access to clinical resources.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

ConforMIS (now restor3d) specializes in patient-specific knee replacement implants manufactured using 3D printing and imaging-based customization. Directly comparable to Additive Orthopaedics on the patient-specific implant model for joint reconstruction, though focused on knee.

TypeDirect peer
Description

Materialise provides patient-specific 3D-printed medical devices and surgical planning software across orthopedic and CMF applications. Both companies use CT-based digital workflows and LPBF to produce custom titanium implants with lattice/porous structures.

TypeDirect peer
Description

Onkos Surgical focuses on patient-specific 3D-printed implants for tumor, revision, and complex orthopedic reconstruction—directly overlapping with Additive Orthopaedics' indications. Both target limb salvage, acetabular revisions, and complex reconstructions through custom titanium solutions.

4Tangible Solutions
TypeEmerging player
Description

Tangible Solutions is a contract manufacturer specializing in medical-grade 3D-printed titanium implants using LPBF technology. Comparable on additive manufacturing process and materials, serving as both an enabler and competitor for orthopedic implant production.

TypeBroad incumbent
Description

Smith+Nephew is a global orthopedic leader with growing investment in 3D-printed and patient-specific implants across hip, knee, and extremities. Comparable to Additive Orthopaedics in indication space, but with substantially greater scale and capital resources.

TypeBroad incumbent
Description

DePuy Synthes is a global orthopedic and spinal implant leader with a portfolio including 3D-printed interbody cages (CONDUIT, EIT Cellular Titanium). Comparable to Additive Orthopaedics on lattice-based osseointegration technology but scaled across a much broader spine/trauma offering.

TypeEmerging player
Description

Medshape (now owned by restor3d) develops patient-specific 3D-printed orthopedic devices with focus on extremities and complex reconstruction. A smaller, niche player with overlapping technology and target indications to Additive Orthopaedics.

TypeDirect peer
Description

4WEB Medical is a direct competitor specializing in 3D-printed orthopedic implants with proprietary lattice structures for spine, foot/ankle, and trauma. Both companies use LPBF titanium printing and lattice-based osseointegration, competing directly for surgeon share in patient-specific and complex orthopedic reconstructions.

TypeBroad incumbent
Description

Stryker is a major orthopedic incumbent with 3D-printed products across knee (Tritanium), hip, and trauma. While its broad portfolio covers similar indications, Stryker's mass-market reach and surgeon relationships create competitive pressure on Additive Orthopaedics across primary and complex revision cases.

TypeDirect peer
Description

Lima Corporate is a leading European orthopedic implant manufacturer with significant 3D-printed and patient-specific product lines (including custom revision hips and extremities). Overlaps with Additive Orthopaedics on patient-specific acetabular revisions and trauma reconstruction.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Additive Orthopaedics

Orthopedic Implantsadditiveorthopaedics.com

Additive Orthopaedics is a privately held medical device company that designs and manufactures patient-specific 3D-printed titanium orthopedic implants using Laser Powder Bed Fusion. It serves orthopedic surgeons, hospitals, and medical device companies with custom implants for complex foot, hip, and segmental bone reconstructions.

What Additive Orthopaedics does

Additive Orthopaedics (legal entity Additive Orthopaedic Technologies Inc.) is a privately held orthopedic technology company founded in 2006 and headquartered in Brattleboro, Vermont. The company designs and manufactures patient-specific 3D-printed titanium orthopedic implants using Laser Powder Bed Fusion (LPBF) of medical-grade Ti-6Al-4V alloy. Its core product portfolio addresses complex anatomical defects that off-the-shelf implants cannot solve, including Total Talus Replacement for foot and ankle reconstruction, an Acetabular Revision System for severe hip defects, and Segmental Bone Reconstruction spacers for trauma, oncology, and chronic-infection cases. Each implant is engineered from patient CT/MRI data using AI-assisted anatomical segmentation to produce a digital twin, with proprietary lattice geometries (600-800 micron interconnected porosity) designed to match cancellous bone modulus and promote bone in-growth.

The company supplements its physical implant business with three content and service platforms: a Clinical Evidence Hub aggregating multi-centered studies on bone in-growth and longitudinal implant performance, a Regulatory Insight Platform providing guidance on FDA 510(k), De Novo, and PMA pathways, and a Surgeons' Portal for licensed orthopedic practitioners. The company cites 15+ advanced regulatory pathways evaluated, 20+ regulatory pathways evaluated, a 98% evidence-based clinical adoption rate, and 5k+ multi-centered clinical studies coordinated as part of its evidence platform. Additional revenue-adjacent services include clinical research and education offerings and regulatory strategy consulting for medical device companies.

The go-to-market is a direct enterprise field-sales model targeting orthopedic surgeons, healthcare institutions, and medical device companies, with regional North American distribution. Revenue is generated on a quote-based, one-time-per-implant basis for the core products, supplemented by professional services revenue from regulatory and clinical research engagements. Pricing is not publicly disclosed. Total known external funding is $1,000,000 from Asimov Ventures in January 2018, and the company operates with 11-50 employees. The customer base consists of individual surgeons, research institutes, surgical centers, and a small number of medtech firms rather than large hospital system contracts.

Additive Orthopaedics firmographics

Firmographics
Name
Additive Orthopaedics
Legal name
Additive Orthopaedic Technologies Inc.
Website
https://additiveorthopaedics.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
Additive Orthopaedics is a privately held medical device company that designs and manufactures patient-specific 3D-printed titanium orthopedic implants using Laser Powder Bed Fusion. It serves orthopedic surgeons, hospitals, and medical device companies with custom implants for complex foot, hip, and segmental bone reconstructions.
Ownership category
akta.pro rank

Additive Orthopaedics industry classification

Industry
Product category
Orthopedic Implants
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • 3D-printed orthopedic implants
  • Patient-specific titanium implants
  • Orthopedic reconstruction devices
  • Additive manufacturing medical
  • Custom orthopedic solutions

Where Additive Orthopaedics is headquartered

Location

Headquarters

HQ city
Little Silver
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Additive Orthopaedics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

  1. Patient-Specific 3D-Printed Implants: Custom-engineered titanium implants designed for individual patient anatomy, primarily targeting complex orthopedic reconstructions including talus replacements, acetabular revisions, and segmental bone reconstruction.
  2. Clinical Research & Education Services: Educational content, research hub services, and clinical evidence resources supporting informed surgical adoption of next-generation orthopedic technologies.
  3. Regulatory Strategy Services: Expert resources and guidance on FDA regulatory pathways including 510(k) submissions, De Novo classifications, and Premarket Approvals (PMA) for medical device companies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Additive Orthopaedics product offering

Product offering

Core offering

Additive Orthopaedics designs, engineers, and manufactures patient-specific 3D-printed orthopedic implants using Laser Powder Bed Fusion (LPBF) on medical-grade Ti-6Al-4V titanium alloy, featuring proprietary lattice geometries (600-800 micron porosity) for bone integration. Core offerings include Total Talus Replacement, Acetabular Revision System, and Segmental Bone Reconstruction solutions, complemented by a Clinical Evidence Hub, Regulatory Insight Platform, and a Surgeons' Portal serving healthcare professionals and medical device developers.

Product overview

Additive Orthopaedics operates as an innovation and education platform offering patient-specific 3D-printed titanium orthopedic implants alongside clinical and regulatory service platforms. The core product portfolio centers on 3D-Printed Implants utilizing Laser Powder Bed Fusion (LPBF) technology, which includes specialized applications: Total Talus Replacement for foot and ankle reconstruction, Acetabular Revision System for hip reconstruction, and Segmental Bone Reconstruction for trauma/oncology cases. These are complemented by the Clinical Evidence Hub for multi-centered research and the Regulatory Insight Platform for FDA pathway guidance. The company also maintains a Surgeons' Portal for healthcare professional access to clinical resources.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 98% evidence-based clinical adoption rate
  • +3 more outcomes

Companies that use Additive Orthopaedics

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Additive Orthopaedics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Additive Orthopaedics partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Additive Orthopaedics competitors and assessment

Company assessment

Direct peers

  • ConforMIS: ConforMIS (now restor3d) specializes in patient-specific knee replacement implants manufactured using 3D printing and imaging-based customization. Directly comparable to Additive Orthopaedics on the patient-specific implant model for joint reconstruction, though focused on knee.
  • Materialise: Materialise provides patient-specific 3D-printed medical devices and surgical planning software across orthopedic and CMF applications. Both companies use CT-based digital workflows and LPBF to produce custom titanium implants with lattice/porous structures.
  • Onkos Surgical: Onkos Surgical focuses on patient-specific 3D-printed implants for tumor, revision, and complex orthopedic reconstruction—directly overlapping with Additive Orthopaedics' indications. Both target limb salvage, acetabular revisions, and complex reconstructions through custom titanium solutions.
  • 4WEB Medical: 4WEB Medical is a direct competitor specializing in 3D-printed orthopedic implants with proprietary lattice structures for spine, foot/ankle, and trauma. Both companies use LPBF titanium printing and lattice-based osseointegration, competing directly for surgeon share in patient-specific and complex orthopedic reconstructions.
  • Lima Corporate: Lima Corporate is a leading European orthopedic implant manufacturer with significant 3D-printed and patient-specific product lines (including custom revision hips and extremities). Overlaps with Additive Orthopaedics on patient-specific acetabular revisions and trauma reconstruction.

Emerging players

  • Tangible Solutions: Tangible Solutions is a contract manufacturer specializing in medical-grade 3D-printed titanium implants using LPBF technology. Comparable on additive manufacturing process and materials, serving as both an enabler and competitor for orthopedic implant production.
  • Medshape: Medshape (now owned by restor3d) develops patient-specific 3D-printed orthopedic devices with focus on extremities and complex reconstruction. A smaller, niche player with overlapping technology and target indications to Additive Orthopaedics.

Broad incumbents

  • Smith+Nephew: Smith+Nephew is a global orthopedic leader with growing investment in 3D-printed and patient-specific implants across hip, knee, and extremities. Comparable to Additive Orthopaedics in indication space, but with substantially greater scale and capital resources.
  • DePuy Synthes (Johnson & Johnson): DePuy Synthes is a global orthopedic and spinal implant leader with a portfolio including 3D-printed interbody cages (CONDUIT, EIT Cellular Titanium). Comparable to Additive Orthopaedics on lattice-based osseointegration technology but scaled across a much broader spine/trauma offering.
  • Stryker: Stryker is a major orthopedic incumbent with 3D-printed products across knee (Tritanium), hip, and trauma. While its broad portfolio covers similar indications, Stryker's mass-market reach and surgeon relationships create competitive pressure on Additive Orthopaedics across primary and complex revision cases.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Additive Orthopaedics social profiles

Digital presence

Additive Orthopaedics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Additive Orthopaedics leadership team

Management profile

Number of profiles

Additive Orthopaedics funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Additive Orthopaedics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Additive Orthopaedics

What does Additive Orthopaedics do?

Additive Orthopaedics designs, engineers, and manufactures patient-specific 3D-printed orthopedic implants using Laser Powder Bed Fusion (LPBF) on medical-grade Ti-6Al-4V titanium alloy, featuring proprietary lattice geometries (600-800 micron porosity) for bone integration. Core offerings include Total Talus Replacement, Acetabular Revision System, and Segmental Bone Reconstruction solutions, complemented by a Clinical Evidence Hub, Regulatory Insight Platform, and a Surgeons' Portal serving healthcare professionals and medical device developers.

Is Additive Orthopaedics a public or private company?

Additive Orthopaedics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Additive Orthopaedics founded?

Additive Orthopaedics was founded in 2006. It employs 11 to 50 people.

Where is Additive Orthopaedics based?

Additive Orthopaedics is headquartered in Little Silver, United States, in the North America region.

How does Additive Orthopaedics make money?

Three revenue lines are on record. Patient-Specific 3D-Printed Implants are the primary driver. The others are clinical Research & Education Services and regulatory Strategy Services.

Who are Additive Orthopaedics's main competitors?

Direct peers on record are ConforMIS, Materialise, Onkos Surgical, 4WEB Medical and Lima Corporate. Emerging players are Tangible Solutions and Medshape. Broad incumbents are Smith+Nephew, DePuy Synthes (Johnson & Johnson) and Stryker.

Does Additive Orthopaedics have an API?

No public API is recorded for Additive Orthopaedics.

What industry is Additive Orthopaedics in?

Additive Orthopaedics's product category is Orthopedic Implants. Its primary akta.pro industry code is HLAHAEAJ, 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireParagon 28®, Inc. Acquires the Assets of Additive OrthopaedicsParagon 28, Inc. announced on June 1, 2021 the acquisition of the product lines and assets of Additive Orthopaedics, a medical device company. The acquired portfolio includes the FDA-approved 3D-printed Patient Specific Talus Spacer, the first and only patient-specific total talus replacement implant authorized in the United States, along with Additive's proprietary pre-operative surgical planning application. The acquisition provides Paragon 28 exclusive access to this innovative implant and accelerates the company's strategy to leverage smart tools, artificial intelligence, and advanced technology to improve patient outcomes in the foot-and-ankle market.PR NewswireParagon 28®, Inc. Acquires the Assets of Additive OrthopaedicsParagon 28, Inc. acquired Additive Orthopaedics' product lines, including an FDA-approved 3D-printed talus spacer for avascular necrosis. The implant, approved February 17, 2021, is the first patient-specific total talus replacement in the U.S. The acquisition also includes a proprietary surgical planning application.PR NewswireAdditive Orthopaedics® Announces New Patient Educational Website www.TotalTalusReplacement.comAdditive Orthopaedics launched a new educational website, www.TotalTalusReplacement.com, to promote its Patient Specific Talus Spacer. The company received FDA approval in February 2021 for this 3D-printed implant, marking it as the first and only patient-specific total talus replacement approved in the United States.PR NewswireAdditive Orthopaedics® Announces FDA Approval of Patient Specific Talus Spacer, First Approved in the U.S.Additive Orthopaedics, LLC received FDA approval via Humanitarian Device Exemption for its Patient Specific Talus Spacer, making it the first and only FDA-approved patient-specific total talus replacement implant in the United States. The 3D-printed implant is indicated for avascular necrosis of the ankle joint and is designed individually for each patient using CT imaging data. The company will immediately begin commercial launch in the U.S., offering patients an alternative to below-the-knee amputation or joint fusion.PR NewswireFDA Approves First in the World, First-of-Its-Kind Implant for the Treatment of Rare Bone Disease as a Humanitarian Use DeviceThe U.S. Food and Drug Administration approved the Patient Specific Talus Spacer, a first-in-the-world 3D-printed talus implant, for humanitarian use to treat avascular necrosis of the ankle joint. The device, developed by Additive Orthopaedics, LLC, provides a joint-sparing alternative to fusion surgery or amputation for patients with late-stage AVN. Clinical data from 31 patients over three years showed decreased pain levels from moderate-to-severe to mild and improved range of motion.PR NewswireAdditive Orthopaedics® Announces First of Its Kind Capability with Patient Specific Implant Locking TechnologyAdditive Orthopaedics, LLC announced a breakthrough in orthopaedic additive manufacturing, becoming the first company capable of incorporating locking technology into patient-specific 3D printed implants, including plates and bone segments. The patent-pending technology addresses the challenge of integrating locking threads into complex, uniquely shaped patient-specific implants, which was previously difficult due to each implant's individual geometry. The company is the only one with FDA 510(k) clearances for patient-specific 3D printed bone segments and plates for foot and ankle applications.PR NewswireAdditive Orthopaedics Announces Receipt of NJ CoVest Fund AwardAdditive Orthopaedics, LLC has been approved for the NJ CoVest Fund through the New Jersey Economic Development Authority, designed to help emerging technology companies bridge funding gaps between product development and commercialization. The company plans to use the funding to expand its workforce and increase production of 3D printed orthopaedic complex reconstruction, limb salvage, and revision implants for patients with conditions lacking commercially available devices. EDA CEO Tim Sullivan highlighted the fund's role in supporting New Jersey's innovation ecosystem and re-establishing the state as a leader in technology development.PR NewswireAdditive Orthopaedics Announces FDA Clearance of their Patient Specific 3D Printed Bone Segments for the Global Extremities MarketAdditive Orthopaedics received FDA 510(k) clearance for its Patient Specific 3D Printed Bone Segments designed for internal bone fixation in the ankle and foot. The company, which has implanted over 1,000 devices since early 2017, recently closed a Series B funding round of $1 million.PR NewswireAdditive Orthopaedics Announces FDA Clearance of their Locking Lattice Plating System for the Global Extremities MarketAdditive Orthopaedics, LLC. announced FDA 510(k) clearance for its 3D printed Locking Lattice Plating System, designed for stabilization and fusion of fractures, osteotomies, and arthrodesis of small bones. This marks the company's third 510(k) clearance leveraging additive manufacturing and fifth product line, with over 300 devices implanted since their first commercial launch at the end of 2016. The company has also recently closed a $1 million Series A funding round.PR NewswireAdditive Orthopaedics Announces the Launch of a Multi-Centered Clinical Study Measuring Bone In-Growth into their 3D Printed Bone SegmentsAdditive Orthopaedics announced the launch of a multi-centered clinical study to measure bone in-growth into their 3D printed bone segments featuring variable honeycomb lattice structures, which the company says show better post-operative success compared to current allograft wedges. The early-stage orthopaedic device company has implanted over 200 individual devices since its first full commercial product launch at the end of 2016 and recently closed a Series A funding round of $1 million.